Answers are grounded in this paper and cite their sources.
A randomized trial evaluates anti-nausea effects of dimenhydrinate and maropitant in dogs, indicating mixed effectiveness.
To determine the anti-nausea and anti-emetic effects of dimenhydrinate and maropitant in dogs when given 60 minutes before hydromorphone and dexmedetomidine. Prospective, randomized, blinded, placebo-controlled clinical trial. A total of 87 healthy client-owned dogs undergoing ovariectomy/castration. Dogs were randomly assigned to be given maropitant (1 mg kg -1 ; group M) subcutaneously (SC), dimenhydrinate (4 mg kg -1 ; group D) intramuscularly (IM), or 0.9% NaCl (0.1 mL kg -1 ; group C) SC 60 minutes before anesthetic premedication with hydromorphone (0.1 mg kg -1 ) and dexmedetomidine (5–15 mcg kg -1 ) IM. Incidences of discomfort after injection of the treatment drug, nausea (ptyalism, lip licking, swallowing), and vomiting/retching were documented. Scores for nausea and sedation were assigned immediately before premedication and for 20 minutes after premedication. Data were analyzed using Fisher’s Exact test and Kruskal-Wallis test, with statistical significance set at p < 0.05. Discomfort to injection was significantly higher in group M (20/31, 64.5%) than in groups D (6/28, 21.4%) and C (2/28, 7.1%) ( p < 0.0001). Incidence of nausea was not significantly different between treatment groups [group M; 23/31 (74.2%) versus group D; 27/28 (96%) versus group C; 23/28 (82.1%), p = 0.050]. The incidence of vomiting/retching was significantly lower in group M (0/31, 0%) compared to groups D (15/28, 53.6%) and C (9/28, 32.1%) ( p < 0.0001). Dimenhydrinate produced no measurable anti-nausea and anti-emetic effect when given 60 minutes before hydromorphone and dexmedetomidine. Maropitant SC prevented hydromorphone-induced emesis but was ineffective in reducing nausea.
No takes yet. Share an insight, caveat, or question.
Shin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: